<?xml version="1.0" encoding="UTF-8"?>
<ref id="B55-biomolecules-10-01625">
 <label>55.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Zhang</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Koh</surname>
    <given-names>C.Y.</given-names>
   </name>
   <name>
    <surname>Ranade</surname>
    <given-names>R.M.</given-names>
   </name>
   <name>
    <surname>Shibata</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Gillespie</surname>
    <given-names>J.R.</given-names>
   </name>
   <name>
    <surname>Hulverson</surname>
    <given-names>M.A.</given-names>
   </name>
   <name>
    <surname>Huang</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Nguyen</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Pendem</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Gelb</surname>
    <given-names>M.H.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>5-Fluoroimidazo[4,5-b]pyridine is a privileged fragment that conveys bioavailability to potent trypanosomal methionyl-tRNA synthetase inhibitors</article-title>
  <source>ACS Infect. Dis.</source>
  <year>2016</year>
  <volume>2</volume>
  <fpage>399</fpage>
  <lpage>404</lpage>
  <pub-id pub-id-type="doi">10.1021/acsinfecdis.6b00036</pub-id>
  <pub-id pub-id-type="pmid">27627628</pub-id>
 </element-citation>
</ref>
